Inhibiting or antagonizing glucagon: making progress in diabetes care (Englisch)
- Neue Suche nach: Lefèbvre, P. J.
- Neue Suche nach: Paquot, N.
- Neue Suche nach: Scheen, A. J.
- Neue Suche nach: Lefèbvre, P. J.
- Neue Suche nach: Paquot, N.
- Neue Suche nach: Scheen, A. J.
In:
Diabetes, Obesity and Metabolism
;
17
, 8
;
720-725
;
2015
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:Inhibiting or antagonizing glucagon: making progress in diabetes care
-
Beteiligte:
-
Erschienen in:Diabetes, Obesity and Metabolism ; 17, 8 ; 720-725
-
Verlag:
- Neue Suche nach: Blackwell Publishing Ltd
-
Erscheinungsdatum:01.08.2015
-
Format / Umfang:6 pages
-
ISSN:
-
DOI:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Englisch
-
Schlagwörter:
-
Datenquelle:
Inhaltsverzeichnis – Band 17, Ausgabe 8
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 713
-
Role of probiotics in reducing the risk of gestational diabetesIsolauri, E. / Rautava, S. / Collado, M. C. / Salminen, S. et al. | 2015
- 720
-
Inhibiting or antagonizing glucagon: making progress in diabetes careLefèbvre, P. J. / Paquot, N. / Scheen, A. J. et al. | 2015
- 726
-
Efficacy and safety of LY2963016 insulin glargine compared with insulin glargine (Lantus®) in patients with type 1 diabetes in a randomized controlled trial: the ELEMENT 1 studyBlevins, T. C. / Dahl, D. / Rosenstock, J. / Ilag, L. L. / Huster, W. J. / Zielonka, J. S. / Pollom, R. K. / Prince, M. J. et al. | 2015
- 734
-
Similar efficacy and safety of LY2963016 insulin glargine and insulin glargine (Lantus®) in patients with type 2 diabetes who were insulin‐naïve or previously treated with insulin glargine: a randomized, double‐blind controlled trial (the ELEMENT 2 study)Rosenstock, J. / Hollander, P. / Bhargava, A. / Ilag, L. L. / Pollom, R. K. / Zielonka, J. S. / Huster, W. J. / Prince, M. J. et al. | 2015
- 742
-
Counter‐regulatory hormone responses to hypoglycaemia in people with type 1 diabetes after 4 weeks of treatment with liraglutide adjunct to insulin: a randomized, placebo‐controlled, double‐blind, crossover trialPieber, T. R. / Deller, S. / Korsatko, S. / Jensen, L. / Christiansen, E. / Madsen, J. / Heller, S. R. et al. | 2015
- 751
-
Two dose‐ranging studies with PF‐04937319, a systemic partial activator of glucokinase, as add‐on therapy to metformin in adults with type 2 diabetesAmin, N. B. / Aggarwal, N. / Pall, D. / Paragh, G. / Denney, W. S. / Le, V. / Riggs, M. / Calle, R. A. et al. | 2015
- 760
-
Pharmacological characterization and antidiabetic activity of a long‐acting glucagon‐like peptide‐1 analogue conjugated to an antithrombin III‐binding pentasaccharidePatterson, S. / de Kort, M. / Irwin, N. / Moffett, R. C. / Dokter, W. H. A. / Bos, E. S. / Miltenburg, A. M. M. / Flatt, P. R. et al. | 2015
- 771
-
Early glycaemic control among patients with type 2 diabetes and initial glucose‐lowering treatment: a 13‐year population‐based cohort studyThomsen, R. W. / Baggesen, L. M. / Svensson, E. / Pedersen, L. / Nørrelund, H. / Buhl, E. S. / Haase, C. L. / Johnsen, S. P. et al. | 2015
- 781
-
Efficacy of a long‐acting C‐peptide analogue against peripheral neuropathy in streptozotocin‐diabetic miceJolivalt, C. G. / Rodriguez, M. / Wahren, J. / Calcutt, N. A. et al. | 2015
- 789
-
Acute but not chronic activation of brain glucagon‐like peptide‐1 receptors enhances glucose‐stimulated insulin secretion in miceTudurí, E. / Beiroa, D. / Porteiro, B. / López, M. / Diéguez, C. / Nogueiras, R. et al. | 2015
- 800
-
Effects of luseogliflozin, a sodium–glucose co‐transporter 2 inhibitor, on 24‐h glucose variability assessed by continuous glucose monitoring in Japanese patients with type 2 diabetes mellitus: a randomized, double‐blind, placebo‐controlled, crossover studyNishimura, R. / Osonoi, T. / Kanada, S. / Jinnouchi, H. / Sugio, K. / Omiya, H. / Ubukata, M. / Sakai, S. / Samukawa, Y. et al. | 2015
- 805
-
Blood pressure‐lowering effect of the sodium glucose co‐transporter‐2 inhibitor ertugliflozin, assessed via ambulatory blood pressure monitoring in patients with type 2 diabetes and hypertensionAmin, N. B. / Wang, X. / Mitchell, J. R. / Lee, D. S. / Nucci, G. / Rusnak, J. M. et al. | 2015
- 809
-
Dapagliflozin‐induced weight loss affects 24‐week glycated haemoglobin and blood pressure levelsSjöström, C. D. / Hashemi, M. / Sugg, J. / Ptaszynska, A. / Johnsson, E. et al. | 2015
- i
-
Diabetes, Obesity and Metabolism| 2015